1. Home
  2. MDGL vs CIG Comparison

MDGL vs CIG Comparison

Compare MDGL & CIG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MDGL
  • CIG
  • Stock Information
  • Founded
  • MDGL 2011
  • CIG 1952
  • Country
  • MDGL United States
  • CIG Brazil
  • Employees
  • MDGL N/A
  • CIG N/A
  • Industry
  • MDGL Biotechnology: Pharmaceutical Preparations
  • CIG Electric Utilities: Central
  • Sector
  • MDGL Health Care
  • CIG Utilities
  • Exchange
  • MDGL Nasdaq
  • CIG Nasdaq
  • Market Cap
  • MDGL 6.1B
  • CIG 5.5B
  • IPO Year
  • MDGL N/A
  • CIG N/A
  • Fundamental
  • Price
  • MDGL $414.68
  • CIG $1.98
  • Analyst Decision
  • MDGL Strong Buy
  • CIG
  • Analyst Count
  • MDGL 8
  • CIG 0
  • Target Price
  • MDGL $445.71
  • CIG N/A
  • AVG Volume (30 Days)
  • MDGL 469.6K
  • CIG 2.4M
  • Earning Date
  • MDGL 08-05-2025
  • CIG 08-14-2025
  • Dividend Yield
  • MDGL N/A
  • CIG 15.19%
  • EPS Growth
  • MDGL N/A
  • CIG N/A
  • EPS
  • MDGL N/A
  • CIG 0.42
  • Revenue
  • MDGL $515,547,000.00
  • CIG $7,700,096,899.00
  • Revenue This Year
  • MDGL $286.67
  • CIG N/A
  • Revenue Next Year
  • MDGL $67.98
  • CIG N/A
  • P/E Ratio
  • MDGL N/A
  • CIG $5.42
  • Revenue Growth
  • MDGL 3421.98
  • CIG 10.77
  • 52 Week Low
  • MDGL $200.63
  • CIG $1.59
  • 52 Week High
  • MDGL $419.99
  • CIG $2.19
  • Technical
  • Relative Strength Index (RSI)
  • MDGL 77.54
  • CIG 58.79
  • Support Level
  • MDGL $351.32
  • CIG $1.90
  • Resistance Level
  • MDGL $393.76
  • CIG $1.97
  • Average True Range (ATR)
  • MDGL 17.32
  • CIG 0.04
  • MACD
  • MDGL 6.15
  • CIG 0.01
  • Stochastic Oscillator
  • MDGL 94.95
  • CIG 90.00

About MDGL Madrigal Pharmaceuticals Inc.

Madrigal Pharmaceuticals Inc is a biopharmaceutical company focused on delivering novel therapeutics for metabolic dysfunction-associated steatohepatitis (MASH), a serious liver disease with high unmet medical need that can lead to cirrhosis, liver failure, and premature mortality. The company's medication, Rezdiffra (resmetirom), is a once-daily, oral, liver-directed thyroid hormone receptor agonist designed to target key underlying causes of MASH.

About CIG Comp En De Mn Cemig ADS

Cia Energetica DE Minas Gerais - Cemig, formerly Energy Company of Minas Gerais, is a Brazilian power company that generates, transmits, and distributes electricity. As one of the power companies in Brazil, the firm operates across Brazilian states and Chile. The company has various subsidiaries and operates chiefly through its generation, transmission, distribution, and gas segments. The majority of the company's revenue is derived from electricity sales to consumers. The company generates power through hydroelectric resources and, secondarily, through thermal and wind resources.

Share on Social Networks: